Cellmax Colorectal Cancer Study
About this study:
CellMax Life is conducting a decentralized clinical research study to gather more information about the efficacy of a Blood Sample Test in identifying the presence of colorectal cancer (CRC) and advanced precancerous lesions (APL) that may cause cancer in the future.
The CellMax First Sight Colorectal Cancer Screening Test is completed in the privacy and comfort of your own home by a home health study nurse. The blood sample is collected within 60 days before a scheduled preventative colonoscopy. Eligible study participants will receive compensation.
Could you participate?
-
Are you between the ages of 45 and 85?
-
Have you been advised to have or have scheduled a screening colonoscopy or have suspected CRC or APL?
-
After providing a blood sample, are you willing to undergo a colonoscopy and willing to grant access to the resulting medical report?
-
Are you at average risk for CRC?
-
Do you have a prior history of malignancies, Ulcerative Colitis or Crohn's Disease?
-
Do you have a family history of Familial Adenomatous Polyposis, Hereditary Nonpolyposis Colorectal Cancer, or other Hereditary Cancer syndromes?